{
  "docId": "019dd923-622c-750b-8b99-38d956541145",
  "docSlug": "a8618aad4c6b",
  "documentTitle": "Stryker Corp. (SYK)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Ben Axler",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2022-04-06 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 188,
  "pageCount": 195,
  "prevPage": 187,
  "nextPage": 189,
  "slideType": "quote_slide",
  "function": "expose_contradiction",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The slide uses a Q&A format to present expert testimony.",
  "elementsJson": [
    "headline_text",
    "quote_block"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-38d956541145/188",
  "deckHref": "/decks/019dd923-622c-750b-8b99-38d956541145",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-38d956541145.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-38d956541145#slide-188",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "With supply chain, I would say the fact that certain components and parts are delayed, and the costs have increased. I think that's gonna have an impact on Stryker. Also if they do not consolidate their facilities and redundancies, it's gonna be a heavy cost for going forward as they continue to grow and acquire.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-25b2-736e-8e59-c9db1de8745a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.1,
        "x": 0.035,
        "y": 0.2
      },
      "kind": "other",
      "text": "Spruce Point Question",
      "attrs": null,
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b70c890-5560-482c-81c1-a13cdb07cd30",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.12,
        "x": 0.025,
        "y": 0.41
      },
      "kind": "other",
      "text": "Former Stryker M&A Professional",
      "attrs": null,
      "subkind": "unclassified",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "754da616-b2d0-4ec5-b3d3-286f5870a7d6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.025,
        "w": 0.83,
        "x": 0.155,
        "y": 0.225
      },
      "kind": "paragraph",
      "text": "What do you think the biggest unappreciated risk is with respect to Stryker?",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "108e3448-e550-48ca-a59f-91615ea64c35",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.83,
        "x": 0.155,
        "y": 0.37
      },
      "kind": "quote",
      "text": "Supply chain and lead times for products as well. With COVID and procedures being canceled, I think COVID is gonna work itself out, but I mean, we said that it's gonna be a year and now we're going on year three. Right. Then hospitals due to, kind of the rates of people in space they've canceled; procedures that they don't deem as essential procedures. Okay. Which would include things like knee replacement or certain back surgeries. So that has had a significant impact. With supply chain, I would say the fact that certain components and parts are delayed, and the costs have increased. I think that's gonna have an impact on Stryker. Also if they do not consolidate their facilities and redundancies, it's gonna be a heavy cost for going forward as they continue to grow and acquire.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0d90ce7a-117a-4801-b5be-23a7a2141596",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"Supply chain and lead times for products as well. With COVID and procedures being canceled, I think COVID is gonna work itself out, but I mean, we said that it's gonna be a year and now we're going on year three. Right. Then hospitals due to, kind of the rates of people in space they've canceled; procedures that they don't deem as essential procedures. Okay. Which would include things like knee replacement or certain back surgeries. So that has had a significant impact. With supply chain, I would say the fact that certain components and parts are delayed, and the costs have increased. I think that's gonna have an impact on Stryker. Also if they do not consolidate their facilities and redundancies, it's gonna be a heavy cost for going forward as they continue to grow and acquire.\" — Former Stryker M&A Professional",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-25b2-736e-8e59-cea81f7f4a0d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.43,
        "x": 0.305,
        "y": 0.06
      },
      "kind": "title",
      "text": "More Insights Into Supply Chain",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9774c343-5a8f-48b0-904d-09f81d83d65c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "ceo-quote-contradiction",
      "slug": null,
      "matchId": "fb6b243b-c910-4aba-909f-f617022deb4a",
      "evidence": "Uses expert testimony to highlight operational risks and potential contradictions in company performance narratives.",
      "confidence": 0.85
    }
  ],
  "arcBeats": [
    {
      "to": 195,
      "from": 61,
      "beatId": "85f871f2-b4a8-4a0d-ac09-177a661eed97",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Resolution",
      "beatSlug": "resolution",
      "evidence": "The document concludes with a clear call to action, urging investors to reconsider their position on Stryker's stock.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}